The methadone clinic monopoly: Opioid treatment chains backed by private equity are fighting calls for reform

Private equity firms have acquired stakes in nearly one-third of all methadone clinics in recent years, gaining outsize control of the U.S. addiction treatment industry even as the country's opioid epidemic has developed into a full-fledged public health crisis.

You are viewing a robot-friendly page.Click hereto reload in standard format.